PL2934528T3 - Hydrazony chinolilowe do leczenia gruźlicy i chorób pokrewnych - Google Patents
Hydrazony chinolilowe do leczenia gruźlicy i chorób pokrewnychInfo
- Publication number
- PL2934528T3 PL2934528T3 PL13811633T PL13811633T PL2934528T3 PL 2934528 T3 PL2934528 T3 PL 2934528T3 PL 13811633 T PL13811633 T PL 13811633T PL 13811633 T PL13811633 T PL 13811633T PL 2934528 T3 PL2934528 T3 PL 2934528T3
- Authority
- PL
- Poland
- Prior art keywords
- hydrazones
- quinolyl
- tuberculosis
- treatment
- related diseases
- Prior art date
Links
- -1 Quinolyl hydrazones Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 201000008827 tuberculosis Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT106651A PT106651A (pt) | 2012-11-20 | 2012-11-20 | Quinolil hidrazonas para o tratamento de tuberculose e doenças relacionadas |
| PCT/PT2013/000069 WO2014081325A1 (en) | 2012-11-20 | 2013-11-20 | Quinolyl hydrazones for the treatment of tuberculosis and related diseases |
| EP13811633.0A EP2934528B1 (en) | 2012-11-20 | 2013-11-20 | Quinolyl hydrazones for the treatment of tuberculosis and related diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2934528T3 true PL2934528T3 (pl) | 2019-05-31 |
Family
ID=49876953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13811633T PL2934528T3 (pl) | 2012-11-20 | 2013-11-20 | Hydrazony chinolilowe do leczenia gruźlicy i chorób pokrewnych |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9809550B2 (pl) |
| EP (1) | EP2934528B1 (pl) |
| BR (1) | BR112015011605A2 (pl) |
| CY (1) | CY1121690T1 (pl) |
| DK (1) | DK2934528T3 (pl) |
| ES (1) | ES2710124T3 (pl) |
| HR (1) | HRP20182198T1 (pl) |
| HU (1) | HUE043021T2 (pl) |
| LT (1) | LT2934528T (pl) |
| MA (1) | MA38207B1 (pl) |
| PL (1) | PL2934528T3 (pl) |
| PT (2) | PT106651A (pl) |
| RS (1) | RS58185B1 (pl) |
| SI (1) | SI2934528T1 (pl) |
| SM (1) | SMT201900089T1 (pl) |
| TR (1) | TR201900156T4 (pl) |
| WO (1) | WO2014081325A1 (pl) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080118576A1 (en) * | 2006-08-28 | 2008-05-22 | Dan Theodorescu | Prediction of an agent's or agents' activity across different cells and tissue types |
| CN102224151A (zh) * | 2008-11-20 | 2011-10-19 | 万能药生物有限公司 | 新的抗微生物剂 |
| EP2287149A1 (en) * | 2009-08-20 | 2011-02-23 | Max-Delbrück-Centrum Für Molekulare Medizin | Enhancers of protein degradation |
| EP2311457A1 (en) * | 2009-10-19 | 2011-04-20 | Forschungszentrum Borstel | Pharmaceutical compositions for treating infections with drug resistant mycobacteria |
| WO2012049161A1 (en) * | 2010-10-13 | 2012-04-19 | Glaxo Group Limited | 3 -amino- pyrazole derivatives useful against tuberculosis |
-
2012
- 2012-11-20 PT PT106651A patent/PT106651A/pt unknown
-
2013
- 2013-11-20 SI SI201331305T patent/SI2934528T1/sl unknown
- 2013-11-20 ES ES13811633T patent/ES2710124T3/es active Active
- 2013-11-20 TR TR2019/00156T patent/TR201900156T4/tr unknown
- 2013-11-20 PT PT13811633T patent/PT2934528T/pt unknown
- 2013-11-20 BR BR112015011605A patent/BR112015011605A2/pt not_active Application Discontinuation
- 2013-11-20 DK DK13811633.0T patent/DK2934528T3/en active
- 2013-11-20 WO PCT/PT2013/000069 patent/WO2014081325A1/en not_active Ceased
- 2013-11-20 US US14/443,787 patent/US9809550B2/en active Active
- 2013-11-20 LT LTEP13811633.0T patent/LT2934528T/lt unknown
- 2013-11-20 RS RS20181598A patent/RS58185B1/sr unknown
- 2013-11-20 MA MA38207A patent/MA38207B1/fr unknown
- 2013-11-20 EP EP13811633.0A patent/EP2934528B1/en active Active
- 2013-11-20 HR HRP20182198TT patent/HRP20182198T1/hr unknown
- 2013-11-20 PL PL13811633T patent/PL2934528T3/pl unknown
- 2013-11-20 HU HUE13811633A patent/HUE043021T2/hu unknown
- 2013-11-20 SM SM20190089T patent/SMT201900089T1/it unknown
-
2019
- 2019-01-09 CY CY20191100018T patent/CY1121690T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA38207A2 (fr) | 2016-12-30 |
| HRP20182198T1 (hr) | 2019-02-22 |
| SMT201900089T1 (it) | 2019-02-28 |
| RS58185B1 (sr) | 2019-03-29 |
| ES2710124T3 (es) | 2019-04-23 |
| EP2934528A1 (en) | 2015-10-28 |
| BR112015011605A2 (pt) | 2017-07-11 |
| WO2014081325A1 (en) | 2014-05-30 |
| LT2934528T (lt) | 2019-02-11 |
| US9809550B2 (en) | 2017-11-07 |
| US20150299128A1 (en) | 2015-10-22 |
| SI2934528T1 (sl) | 2019-03-29 |
| HUE043021T2 (hu) | 2019-08-28 |
| EP2934528B1 (en) | 2018-11-07 |
| PT106651A (pt) | 2014-05-20 |
| TR201900156T4 (tr) | 2019-02-21 |
| PT2934528T (pt) | 2019-03-20 |
| DK2934528T3 (en) | 2019-02-04 |
| MA38207B1 (fr) | 2018-06-29 |
| CY1121690T1 (el) | 2020-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289974A (en) | Methods and processes for the non-invasive evaluation of genetic variations | |
| IL269567A (en) | Methods and processes for non-invasive evaluation of genetic variations | |
| EP2890440A4 (en) | DEVICES AND METHOD FOR THE TREATMENT OF VASCULAR DISEASES | |
| ZA201506984B (en) | Microarray for delivery of therapeutic agent and methods of use | |
| PL2825161T3 (pl) | Inhibitory ludzkiej ezh2 i sposoby ich zastosowania | |
| IL242903B (en) | Methods and processes for non-invasive evaluation of genetic variations | |
| IL239557A0 (en) | Microarray for providing therapeutic material and methods for use | |
| IL237070B (en) | Treatment of vaccine-related diseases and inflammatory diseases | |
| PL2981921T3 (pl) | Metody i procesy nieinwazyjnej oceny zmienności genetycznych | |
| IL239368A0 (en) | Sparing–ppar thiazolidinediones and combinations for the treatment of neurodegenerative diseases of the nervous system | |
| HUE051632T2 (hu) | Betegségek kezelésére szolgáló készítmények és eljárások | |
| IL234606B (en) | Novel methods and composition for treatment of disease | |
| SI2900230T1 (sl) | Sestavki za zdravljenje debelosti in postopki njihove uporabe | |
| EP2670438A4 (en) | SELECTION AND TREATMENT OF PATIENTS | |
| EP2934501A4 (en) | USES AND METHOD FOR THE TREATMENT OF LIVER DISEASES OR DRESSES | |
| ZA201503266B (en) | Pyidone derivatives and uses thereof in the treatment of tuberculosis | |
| PL2922541T3 (pl) | Hydrazony pirydylowe do leczenia gruźlicy i chorób pokrewnych | |
| SI2934528T1 (sl) | Kinolil hidrazoni za zdravljenje tuberkuloze in povezanih bolezni | |
| GB201203663D0 (en) | Note pad and method of use thereof | |
| AP2015008270A0 (en) | Preparation for the treatment of tuberculosis |